法国诺上腺素剂量:是时候向前迈进了!
Isabelle Goyer1, Ines Lakbar2, Yonathan Freund3
1Department of Pharmacy, CHU de Caen, Caen, France.
Anaesthesia, critical care & pain medicine
|May 31, 2024
概括
由于盐配方,北上腺素的剂量在全球范围内有所不同,这会影响患者的护理. 标准化实践对于准确的急性心血管衰竭治疗和研究比较至关重要.
科学领域:
- 药理学和重症监护医学 药理学和重症监护医学
背景情况:
- 上腺素是急性心血管衰竭的重要一线血管压缩剂.
- 准确的上腺素剂量对于患者评估,比较研究和有针对性的干预措施至关重要.
- 在不同国家和制造商之间存在对诺阿皮内林产品配方的差异.
研究的目的:
- 为了突出noradinephrine剂量实践中的差异.
- 为了解释盐配方如何影响产品总重量,而诺阿基因基保持不变.
- 提出改善临床实践和研究间比较的建议.
主要方法:
- 审查现有的关于北上腺素配方和剂量的文献.
- 分析不同形式的盐对药物度的影响.
- 综合证据,以确定与配方变化相关的风险.
主要成果:
- 上腺素产品以盐的形式配制,影响总重量,但不影响活性上腺素基.
- 这些配方差异导致药剂和临床实践的显著差异.
- 缺乏标准化在患者评估,治疗和研究可比性方面存在风险.
结论:
- 诺拉上腺素盐配方的差异需要仔细注意剂量.
- 实践的标准化对于减轻风险和确保一致的患者护理至关重要.
- 提供了建议,以解决这些在临床和研究层面的变化.
相关概念视频
Adrenergic Agonists: Therapeutic Uses
766
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
766
Adrenergic Agonists: Mixed-Action Agents
701
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
701
Adrenergic Neurons: Neurotransmission
3.7K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.7K
Adrenergic Agonists: Therapeutic Classification
767
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
767
Adrenergic Agonists: Direct-Acting Agents
1.4K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.4K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
709
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
709


